# Calcinosis Reduction by Pyrophosphate in SSC

> **NCT04966416** · NA · NOT_YET_RECRUITING · sponsor: **Szeged University** · enrollment: 60 (estimated)

## Conditions studied

- Systemic Sclerosis
- Scleroderma

## Interventions

- **DIETARY_SUPPLEMENT:** Pyrophosphate
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04966416
- **Lead sponsor:** Szeged University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04966416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04966416, "Calcinosis Reduction by Pyrophosphate in SSC". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04966416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*